Cardionyx
Founded in 2020, Cardionyx Heart Science Ltd. is dedicated to transforming heart failure treatment with cutting-edge neuromodulation technology. Their mission is to deliver safer, smarter, and more adaptable solutions that improve patient lives worldwide. They develop AI-driven implant systems that offer personalized, real-time heart failure management through minimally invasive procedures, remote monitoring, and adaptive therapy.
Industries
Products
AI-driven implantable closed-loop neuromodulation system
An integrated system composed of a venous implant for sensing and stimulation, a subcutaneous AI control unit that adaptively modulates stimulation, and a wireless application for remote monitoring and adjustments to manage heart failure by regulating autonomic tone.
AI-driven implantable closed-loop neuromodulation system
An integrated system composed of a venous implant for sensing and stimulation, a subcutaneous AI control unit that adaptively modulates stimulation, and a wireless application for remote monitoring and adjustments to manage heart failure by regulating autonomic tone.
Services
Remote monitoring and non-invasive therapy adjustment
Continuous remote access to device telemetry and the ability to adjust therapy parameters via a secure wireless application to support clinician-led care without additional procedures.
Remote monitoring and non-invasive therapy adjustment
Continuous remote access to device telemetry and the ability to adjust therapy parameters via a secure wireless application to support clinician-led care without additional procedures.
Expertise Areas
- Neuromodulation for cardiovascular disease
- Closed-loop physiological control systems
- AI-driven personalized therapy
- Implantable medical device design and integration
Key Technologies
- Baroreceptor-targeted neuromodulation
- Implantable physiological sensors
- Closed-loop control systems
- Adaptive machine learning for therapy optimization